Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

The FDA approved Eli Lilly's Zepbound for treating obstructive sleep apnea in obese adults, marking a significant advancement in addressing this widespread disorder and expanding market potential.

FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall

Viking Therapeutics stock surges 12% amid Novo Nordisk trial woes

Novo Nordisk sinks on latest data, Lilly gains

Novo Nordisk shares fell nearly 28% after CagriSema's trial results showed lower than expected weight loss, while Eli Lilly's shares rose 10% amidst the news.

Novo slumps, Lilly gains on trial data results

Novo Nordisk's shares fell 19% after phase 3 trial results for CagriSema, an obesity drug, disappointed. Eli Lilly's stock rose amid growing confidence in its obesity treatments.

Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints

Novo Nordisk's obesity drug CagriSema showed a 22.7% weight loss in trials, disappointing investors and causing a significant drop in market value amid fierce competition.

In weight loss battle, Novo and Lilly face growing offensive from licensed copies

Novo Nordisk and Eli Lilly face competition from cheaper drug copies abroad, threatening their market share and prompting potential price declines amid rising global obesity rates.

Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over

Eli Lilly's stock dropped slightly despite the FDA declaring the tirzepatide shortage resolved, although a trade group claims ongoing supply issues persist for compounded versions.

Eli Lilly's Alzheimer's treatment approved in China

Eli Lilly’s Kisunla is approved in China for early Alzheimer's, marking a new treatment option alongside Leqembi, with specific dosing and safety profiles.

Eli Lilly Alzheimer’s drug donanemab approved in China

Eli Lilly's Kisunla treatment for Alzheimer's has been approved in China, following its approval in the U.S., Japan, and the UK, marking an important milestone in Alzheimer’s therapies.